Ultragenyx Pharmaceutical RARE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 23.00 | 105.18 | -1.28 | -113,283 | -129 | |
| 2025Q3 | 30.08 | 102.90 | -1.81 | -170,890 | -180 | |
| 2025Q2 | 36.36 | 107.94 | -1.17 | -107,888 | -115 | |
| 2025Q1 | 36.21 | 105.67 | -1.57 | -142,939 | -151 | |
| 2024Q4 | 42.07 | 105.11 | -1.38 | -122,278 | -133 | |
| 2024Q3 | 55.55 | 111.68 | -1.37 | -131,987 | -134 | |
| 2024Q2 | 41.10 | 105.03 | -1.51 | -116,361 | -132 | |
| 2024Q1 | 46.69 | 104.57 | -2.03 | -165,347 | -171 | |
| 2023Q4 | 47.82 | 109.51 | -1.44 | -122,049 | -123 | |
| 2023Q3 | 35.65 | 103.70 | -2.23 | -145,097 | -160 | |
| 2023Q2 | 46.13 | 102.76 | -2.25 | -147,957 | -160 | |
| 2023Q1 | 40.10 | 104.47 | -2.33 | -154,105 | -164 | |
| 2022Q4 | 46.33 | 104.58 | -2.16 | -145,628 | -152 | |
| 2022Q3 | 41.41 | 101.07 | -3.51 | -225,066 | -245 | |
| 2022Q2 | 59.66 | 99.98 | -2.26 | -141,593 | -158 | |
| 2022Q1 | 72.62 | 100.58 | -2.19 | -136,632 | -152 | |
| 2021Q4 | 84.09 | 100.03 | -1.79 | -102,564 | -122 | |
| 2021Q3 | 90.19 | 99.99 | -1.07 | -89,828 | -73 | |
| 2021Q2 | 95.35 | 100.45 | -1.81 | -82,776 | -122 | |
| 2021Q1 | 113.86 | 99.85 | -2.03 | -106,569 | -136 |